Arkolith/Insider Trading/ZVRA/Form 4

Quartel Adrian W

Chief Medical OfficerZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$40K
Net Open-Market Flow
-$40K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2026Sell(S)5K$8.83$40K10K
Jan 30, 2026Option exercise(M)11K——14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2026Option exercise(M)11K—$023K
Jan 29, 2026Grant(A)38K—$038K
Jan 29, 2026Grant(A)75K—$075K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001910132-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML